Onyx Pharmaceuticals ONXX

Bayer ( BAYRY.PK ) and Onyx Pharmaceuticals ( ONXX ) announce a Phase 3 trial of Nexavar tablets in patients with certain lung cancers did not meet its primary endpoint of improving overall survival. Post your comment!

By Doolan Wesley : Investing in biotech companies can be viewed as "risky business" in today's world, with the FDA having a tight grip over the regulations needed for a product to reach the market. This year though, Discovery Laboratories Inc. ( DSCO ) introduced not one, but two new products to ...

Premarket gainers: VELT +11% . SHLD +10% . CTRP +9% . BYD +7% . GALE +6% . ONXX +6% . HLF +5% . Losers: AAP -11% . DNDN -6% . Post your comment!

By Helix Investment Management : Of all the sectors in the stock market, no sector moves more due to corporate developments than the biotechnology sector. A single drug trial or FDA decision can send stocks soaring, or plunging. Due to this trend, many investors choose to trade biotechnology stocks

By Ganaxi Small Cap Movers : Switzerland-based BB Biotech, founded in 1993, is one of the largest pure-play biotech investment companies, and also a public company with its shares are listed on the Swiss Stock Market. About a third of its assets are invested in oncology-focused biotech companies,

By StockPandit : So far, 2012 has been the best year for the biotechnology and drugs industry. So many stocks surged in the last four months based on clinical trial results, FDA approval, FDA advisory committee recommendation, European commission approval, recommendation from independent ...